A Microfiltration Device for Urogenital Schistosomiasis Diagnostics

A Microfiltration Device for Urogenital Schistosomiasis Diagnostics

Schistosomiasis is a parasitic disease affecting over 200 million people worldwide. This study reports the design and development of a microfiltration device for isolating schistosome eggs in urine for rapid diagnostics of urogenital schistosomiasis. The design of the device comprises a linear array of microfluidic traps to immobilize and separate schistosome eggs. Sequential loading of individ...

New research tools for urogenital schistosomiasis.

Approximately 200,000,000 people have schistosomiasis (schistosome infection). Among the schistosomes, Schistosoma haematobium is responsible for the most infections, which are present in 110 million people globally, mostly in sub-Saharan Africa. This pathogen causes an astonishing breadth of sequelae: hematuria, anemia, dysuria, stunting, uremia, bladder cancer, urosepsis, and human immunodefi...

EAU Guidelines EAU Guidelines for the Management of Urogenital Schistosomiasis

EAU guidelines for the management of urogenital schistosomiasis.

More than 100 million people worldwide are affected by bilharziasis, caused by Schistosoma haematobium. For travellers precaution is most important. For the population in endemic areas, an integrated approach including health education is necessary. Effective pharmacologic treatment is available.

Urogenital Schistosomiasis: No Longer a Diagnosis of the Developing World

Schistosomiasis is a chronic, parasitic disease caused by the blood flukes (trematode worms) of the genus Schistosoma. There are two major forms of schistosomiasis, intestinal and urogenital. The blood fluke Schistosoma haematobium causes urogenital schistosomiasis, with its highest prevalence in Africa and the Middle East. Given the emerging migrant populations in Australia, from the Africa an...